Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-02

Clinical Trial Update: Effect of Whole Body Electromyostimulation and/or Protein Supplementation on Sarcopenic Obesity in 70+ [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whole-body electromyostimulation and protein supplementation for sarcopenic obesity in adults aged 70 and older; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Sarcopenic Obesity | Phase 3 | Status: COMPLETED